Novo Nordisk advancing hemophilia drug along regulatory pathway
Novo Nordisk has announced positive results from a Phase 3 study assessing the efficacy and safety of concizumab, its prophylactic treatment of hemophilia A or B with inhibitors.
Archives for July 12, 2022
Mission Bio looks to accelerate solid tumor research
San Francisco, California-based Mission Bio is expanding its single-cell DNA toolset.
BioNTech to take malaria vaccine into clinical trials later this year
BioNTech is readying to take its mRNA malaria vaccine candidates into clinical trials later this year.
Vertex to acquire ViaCyte, targeting type 1 diabetes
Vertex Pharmaceuticals will acquire ViaCyte, a privately held biotech focused on delivering novel stem cell-derived cell replacement therapies as a functional cure for type 1 diabetes (T1D), for $320m.